Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 51 - 75 of 2342 in total
Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT01
  • Branched Forssman(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260316 1794.961516 C82H146N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT02
  • Branched Forssman(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260317 1822.992816 C84H150N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT03
  • Branched Forssman(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260318 1851.024116 C86H154N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT04
  • Branched Forssman(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260319 1879.055416 C88H158N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT05
  • Branched Forssman(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260320 1907.086716 C90H162N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT07
  • Branched Forssman(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260322 1905.071066 C90H160N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT06
  • Branched Forssman(d18:1/26:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260321 1935.118016 C92H166N4O38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT08
  • Branched Forssman(d18:1/26:1(17Z))
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260323 1933.102366 C92H164N4O38
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AC00
  • CHS
  • GalNAcb1-4(GlcNAca1-2Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AB00
  • CPS
  • GalNAcb1-4(Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
Simple Glc series LMSP05010104
  • Catacerebroside A
  • N-(2R-hydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
10930878 837.669384 C49H91NO9
Simple Glc series LMSP05010105
  • Catacerebroside B
  • N-(2R-hydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-4R-hydroxy-sphinganine
10909053 843.679949 C48H93NO10
Simple Glc series LMSP05010106
  • Catacerebroside C
  • N-(2,3-dihydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-4R-hydroxy-sphinganine
11768080 859.674864 C48H93NO11
Simple Glc series LMSP05010132
  • Cerebroside A
  • N-(2-hydroxy-3E-hexadecenoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
171119588 725.544184 C41H75NO9
Simple Glc series LMSP05010133
  • Cerebroside B
  • N-(2-hydroxy-hexadecanoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
171119589 727.559834 C41H77NO9
Simple Glc series LMSP05010134
  • Cerebroside C
  • N-(2-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
171119590 753.575484 C43H79NO9
Simple Glc series LMSP05010135
  • Cerebroside D
  • N-(2-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
100978059 755.591134 C43H81NO9
Simple Glc series LMSP05010102
  • Cerebroside E
  • N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-pentadecasphing-4E,8E-dienine
127034832 713.544184 C40H75NO9
Simple Glc series LMSP05010096
  • Chrysogeside A
  • N-(2R-hydroxy-3E-octadecenoyl)-1-beta-D-glucopyranosyl-hexadecasphing-4E,8Z-dienine
53355808 68069 711.528534 C40H73NO9
Simple Glc series LMSP05010094
  • Chrysogeside B
  • N-(2R-hydroxy-3E-nonadecenoyl)-1-beta-D-glucopyranosyl-9-methyl-pentadecasphing-4E,8E-dienine
53262842 68070 725.544184 C41H75NO9
Simple Glc series LMSP05010095
  • Chrysogeside C
  • N-(2R-hydroxy-3E-nonadecenoyl)-1-beta-D-glucopyranosyl-9-methyl-tetradecasphing-4E,8E-dienine
53355809 68071 711.528534 C40H73NO9
Simple Glc series LMSP05010092
  • Chrysogeside D
  • N-(2R-hydroxy-3E-nonadecenoyl)-1-beta-D-glucopyranosyl-9-methyl-heptadecasphing-4E,8E-dienine
53355905 68072 753.575484 C43H79NO9
Simple Glc series LMSP05010093
  • Chrysogeside E
  • N-(2R-hydroxy-nonadecanoyl)-1-beta-D-glucopyranosyl-9-methyl-pentadecasphing-4E,8E-dienine
53355906 68073 727.559834 C41H77NO9
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG00
  • ClcNAc-Lex-5
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1268
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG01
  • ClcNAc-Lex-5(d18:1/16:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261436 1575.887227 C74H133N3O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024